SSRIs and Dutch general practitioners;SSRI's in de Nederlandse huisartsenpraktijk

Huisarts en Wetenschap

Volumn 53, Issue 6, 2010, Pages 302-305

  Ketelaar, Miriam ^a   Grundmeijer, Hans ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE;

AGED; ANXIETY DISORDER; ARTICLE; DEPRESSION; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; NETHERLANDS; PATIENT COMPLIANCE; PRESCRIPTION; SELF REPORT; TREATMENT DURATION; TREATMENT INDICATION;

EID: 77954128505     PISSN: 00187070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12445-010-0139-8     Document Type: Article

References (14)

1. Stichting Farmaceutische Kengetallen. Antidepressiva weer in de lift. Pharmaceutisch Weekblad 2007;142:13.
2. Stichting Farmaceutische Kengetallen. Gebruik antidepressive stijgt sterk. Pharmaceutisch Weekblad 2005;140:767.
3. De Hooge-Verweijen AK. Persoonlijke mededeling op 31-10-2007, namens de Stichting Farmaceutische Kengetallen.
4. Centraal Bureau voor de Statistiek, Bevolking per 4-cijferige postcode, Diemen, 2006. http://statline.cbs.nl, geraadpleegd op 21-11-2007.
5. Van Marwijk HWJ, Grundmeijer HGLM. Bijl D, Van Gelderen MG, De Haan M, Van Weel-Baumgarten EM, et al. NHG-Standaard Depressieve stoornis (depressie) (Eerste herziening). Huisarts Wet 2003;46:614-33.
6. Terluin B, Van Heest FB, Van der Meer K, Neomagus GJH, Hekman J, Aulbers LPJ, et al. NHG-Standaard Angststoornissen (Eerste herziening). Huisarts Wet 2004;47:26-37.
7. College voor zorgverzekeringen (CVZ). Farmacotherapeutisch Kompas. Diemen, College voor zorgverzekeringen 2006. Beschikbaar via www.fk.cvz.nl.
8. Meijer WEE, Heerding ER, Leufkens HGM. Incidence and determinants of long-term use of antidepressants. Eur J Clin Pharmacol 2004;60:57-61. (Pubitemid 38471459)
9. Taylor MJ, Freemantle N, Geddes JR, Bhagwagar Z. Early onset of selective serotonin reuptake inhibitor antidepressant action. Systematic review and meta-analysis. Arch Gen Psychiatry 2006;63:1217-23.
10. Verbeek-Heida PM, Mathot EF. Better safe than sorry - why patients prefer to stop using selective serotonin reuptake inhibitor (SSRI) antidepressants but are afraid to do so: Results of a qualitative study. Pharmacoepidemiol Drug Saf 2007;16:1054-62.
11. Terluin B, Van Marwijk HWJ, Adèr HJ, De Vet HCW, Penninx BWJH, Hermens MLM, et al. The Four-Dimensional Symptom Questionnaire (4DSQ): a validation study of a multidimensional self-report questionnaire to assess distress, depression, anxiety and somatization. BMC Psychiatry 2006;6:34.
12. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Medicine 2008;5:260-8.
13. Cohen D. Should the use of selective serotonin reuptake inhibitors in child and adolescent depression be banned? Psychother Psychosom 2007;76:5-14.
14. Usala T, Clavenna A, Zuddas A, Bonati M. Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: A systematic review and meta-analysis. Eur Neuropsychopharmacol 2008;18:62-73. (Pubitemid 350213389)